BD Biosciences Wrap up
Projecting 6-8% top-line growth
Leveraging top-line growth and operational efficiencies to drive the bottom line
Objective is to drive revenue growth to ᡂ%
Strengthening leadership and expanding market share
Previous slide
Next slide
Back to first slide
View graphic version